Steven Dubinett
Institution Name:
University of California, Los Angeles
Total Awards:
1
Award Value:
$11,815,315
Awards as PI
Program Type | Institution | Grant Title | Award Value |
---|---|---|---|
Clinical Trial Stage Projects | University of California, Los Angeles | A phase I trial of intratumoral administration of CCL21-gene modified dendritic cell (DC) combined with intravenous pembrolizumab for advanced NSCLC | $11,815,315 |
Total: $11,815,315.00 |